Radiopharm Theranostics RADX
NASDAQ RADX
$1.55 -0.07 (-4.49%)
As of: Oct 1, 2026 · 12:27 PM EDT

Radiopharm Theranostics (RADX) Other Non-Current Liabilities (2024 - 2025)

Updated

Radiopharm Theranostics (RADX) reported Other Non-Current Liabilities of $5,441 for fiscal Q4 2025 (quarter ended Jun 30, 2025), down 2.8% from $5,599 a year earlier.

Analysis

Radiopharm Theranostics (RADX) Other Non-Current Liabilities (2024 - 2025) Analysis & Trends

At the end of FY2025 (ended Jun 30, 2025), Radiopharm Theranostics posted Other Non-Current Liabilities of $849,544, unchanged from FY2024.

  • By fiscal year, Other Non-Current Liabilities came in at $849,544 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Radiopharm Theranostics 5.74 Bn 5.70 Bn 186,835.86
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 5,440.76
Dec 31, 2024 849,544.00
Jun 30, 2024 5,598.70
API Access

Radiopharm Theranostics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RADX&period=max&api_key=YOUR_API_KEY